Vinpai: AMF Approves Simplified Takeover Bid by Camlin Fine Sciences at €3.60 per Share
The French Financial Markets Authority approved on Thursday the simplified public takeover offer launched by Indian group Camlin Fine Sciences to acquire the remaining shares of Vinpai at a price of €3.60 per share.
Camlin Fine Sciences Limited, an Indian company listed on the Mumbai Stock Exchange, initially acquired 78.68% of Vinpai's capital on November 27, 2025, through a contribution in kind at a price of €3.60 per share. The group then subscribed to 1.1 million new shares resulting from the conversion of convertible bonds, increasing its stake to 83.82% of the capital and 80.85% of the voting rights.
Details of the Offer and Availability of Documents
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The simplified public takeover offer targets the remaining shares of Vinpai at the same price of €3.60 per share. Documents detailing the schedule and conditions of the offer were made available on Thursday by Camlin Fine Sciences on the websites of the AMF, the acquiring group, and Vinpai. ALLinvest Securities is acting as the presenting institution for the offer, while Fontaine Avocats serves as legal counsel.
Related
SectorAgroalimentaire et boissons›Industrie alimentaire
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 3,8 millions d'euros
Quarterly revenue: 3,8 millions d'euros
EBITDA: -1,2 millions d'euros
Net income: -1,7 millions d'euros
Guidance from the release
« Vinpai entend reprendre sa dynamique de croissance historique » mais sans objectifs chiffrés explicites ; dépendance au soutien de la maison mère
Risks mentioned
Arrêt soudain des expéditions en Algérie au T2 2026 impactant significativement les résultats financiers
Forte dépendance aux clients du Moyen-Orient et Afrique (représentaient plus de 50% du CA jusqu'en 2025)
Pression sur la marge brute due à un mix produit défavorable
Opportunities identified
Utilisation de l'organisation de vente de CAMLIN Fine Sciences Limited pour augmenter significativement les ventes
Carnet de commandes de 2,8 M€ (stable vs 2,7 M€ à juin 2025) offrant une base de relance
Croissance significative en Europe (hors France) : +233% (€945k vs €283k en 2025)
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
